purine has been researched along with Neurodegenerative Diseases in 2 studies
1H-purine : The 1H-tautomer of purine.
3H-purine : The 3H-tautomer of purine.
9H-purine : The 9H-tautomer of purine.
7H-purine : The 7H-tautomer of purine.
Neurodegenerative Diseases: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Because massive extracellular release of ATP often occurs by lytic and non-lytic mechanisms, especially after stressful events and pathological conditions, purinergic signalling is correlated to and involved in the aetiopathology and/or progression of many neurodegenerative diseases." | 4.85 | Membrane compartments and purinergic signalling: P2X receptors in neurodegenerative and neuroinflammatory events. ( Amadio, S; Apolloni, S; Finocchi, P; Montilli, C, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koch, P | 1 |
| Akkari, R | 1 |
| Brunschweiger, A | 1 |
| Borrmann, T | 1 |
| Schlenk, M | 1 |
| Küppers, P | 1 |
| Köse, M | 1 |
| Radjainia, H | 1 |
| Hockemeyer, J | 1 |
| Drabczyńska, A | 1 |
| Kieć-Kononowicz, K | 1 |
| Müller, CE | 1 |
| Apolloni, S | 1 |
| Montilli, C | 1 |
| Finocchi, P | 1 |
| Amadio, S | 1 |
1 review available for purine and Neurodegenerative Diseases
| Article | Year |
|---|---|
Membrane compartments and purinergic signalling: P2X receptors in neurodegenerative and neuroinflammatory events.
Topics: Animals; Humans; Inflammation; Neurodegenerative Diseases; Purines; Receptors, Purinergic P2; Recept | 2009 |
1 other study available for purine and Neurodegenerative Diseases
| Article | Year |
|---|---|
1,3-Dialkyl-substituted tetrahydropyrimido[1,2-f]purine-2,4-diones as multiple target drugs for the potential treatment of neurodegenerative diseases.
Topics: Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Animals; Caffeine; CHO Cells; | 2013 |